Skip to main content
Elanix Biotechnologies AG logo

Elanix Biotechnologies AG — Investor Relations & Filings

Ticker · ELN ISIN · DE000A0WMJQ4 LEI · 391200SYNFFL0NPAJK90 F Manufacturing
Open in API
Filings indexed 161 across all filing types
Latest filing 2016-06-07 Declaration of Voting R…
Country DE Germany
Listing F ELN

About Elanix Biotechnologies AG

https://elanixbiotechnologies.com/

Elanix Biotechnologies AG is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological, and gynecological applications. The company's core focus is on creating therapeutic solutions derived from progenitor cells. Its product development pipeline aims to provide advanced treatments for skin and tissue repair.

Recent filings

Filing Released Lang Actions
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly references Article 26a of the WpHG (German Securities Trading Act). It announces the 'New total number of voting rights' as 5,261,000, resulting from an 'Other capital measure' effective on June 6, 2016. This type of announcement, dealing with the total number of shares/voting rights, is a specific regulatory disclosure. While it relates to capital structure, it is not a general financing update (CAP) or a share issue/repurchase report (SHA/POS). It is a specific regulatory notification regarding voting rights, which fits best under the general 'Regulatory Filings' (RNS) category as a specific regulatory disclosure that doesn't match the other specialized codes, although it is closely related to capital changes. Given the options, RNS is the most appropriate fallback for specific regulatory announcements not covered elsewhere, or it could be argued as a form of Capital/Financing Update (CAP) if the voting rights change is due to a capital event. However, since it is a mandatory disclosure about the *total number* of rights, RNS is safer, but let's re-evaluate against CAP. CAP is for fundraising/financing activities. Since this is a notification of the *result* of a capital measure (conditional capital increase/other measure), it is a direct consequence of a financing/capital event. Given the specificity of the other codes, RNS (Regulatory Filings) is the standard catch-all for mandatory disclosures like this that aren't 10-K, ER, or IR. However, the content is fundamentally about the capital structure resulting from a measure. Since there is no specific code for 'Total Voting Rights Announcement', RNS is the best fit as a general regulatory filing.
2016-06-07 English
Report Publication Announcement 2016
Report Publication Announcement Classification · 100% confidence The document is titled 'Preliminary announcement of the publication of financial reports' and explicitly states that the 'Annual financial report of the group' will be disclosed on a future date (April 29, 2016). The text is very short (1525 characters) and serves only to announce the upcoming release of a report, not to contain the report itself. This perfectly matches the definition of a Report Publication Announcement (RPA), which is used when a document announces the timing or release of another report, adhering to the 'MENU VS MEAL' rule.
2016-04-26 English
Elanix Biotechnologies AG beschliet Kapitalerhohung
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Elanix Biotechnologies AG beschließt Kapitalerhöhung' (Elanix Biotechnologies AG resolves capital increase) and explicitly mentions 'Kapitalerhöhung/Kapitalmaßnahme' (Capital Increase/Capital Measure) as a keyword. The text details the board's decision to execute a capital increase against cash contributions, specifying the new share issuance amount and the intended use of the proceeds (product sales preparation and industrialization). This directly aligns with the definition of 'Capital/Financing Update'. The document length is short (2715 chars) and it is an 'Ad-hoc' announcement, which fits the pattern of a specific corporate action announcement rather than a comprehensive report.
2016-04-15 German
Elanix Biotechnologies AG: Erweiterung des Vorstands, Wahl des Aufsichtsratsvorsitzenden
Board/Management Information Classification · 100% confidence The document is an 'Ad-hoc' announcement dated February 15, 2016, explicitly stating changes in corporate governance: the expansion of the Management Board ('Erweiterung des Vorstands') and the election of the Chairman of the Supervisory Board ('Wahl des Aufsichtsratsvorsitzenden'). It details the appointment of new board members and executives. This content directly aligns with the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2016-02-15 German
Elanix Biotechnologies AG: Neubesetzung des Aufsichtsrates
Board/Management Information Classification · 100% confidence The document is titled 'Elanix Biotechnologies AG: Neubesetzung des Aufsichtsrates' (Resignation/Appointment of the Supervisory Board). It explicitly announces that current members of the Supervisory Board are resigning and replacement members are being appointed, effective February 5, 2016. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2016-01-04 German
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'DGAP Voting Rights Announcement' and details a 'Correction of a notification of Major Holding' concerning the acquisition/disposal of shares with voting rights, referencing specific sections of the German Securities Trading Act (WpHG). This content directly relates to changes in significant share ownership thresholds. This aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is a regulatory announcement, MRQ is a more specific category than the general RNS fallback.
2015-12-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.